<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14867">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01786408</url>
  </required_header>
  <id_info>
    <org_study_id>13-P001</org_study_id>
    <nct_id>NCT01786408</nct_id>
  </id_info>
  <brief_title>A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate</brief_title>
  <official_title>A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick Using the SAFE-T-FILL Capillary Blood Collection System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seventh Sense Biosystems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seventh Sense Biosystems</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will involve an investigational device, the Seventh Sense Biosystems TAP20-C. The
      TAP20-C device collects small amounts of blood from the forearm which can then be used for
      blood testing. The study will also involve collecting blood by fingerstick which is a common
      way of collecting blood.  The SAFE-T-FILL Capillary Blood Collection system and the Terumo
      Capiject 1.5 mm Blade Safety Lancet will be used for this.  The study will compare the
      concentrations of glucose, hemoglobin, and HbA1C in blood samples collected with the two
      different blood collection methods. Additional information will be collected about how the
      TAP20-C device performs.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Non-Inferiority of Analyte Levels</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study will compare the concentrations of glucose, hemoglobin, and HbA1C in blood samples collected with the two different blood collection methods in a single two hour session.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diabetes</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>TAP20-C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single Use Integrated Capillary Blood Collection System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAFE-T-FILL CAPILLARY SYSTEM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single Use Capillary Blood Collection System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAP20-C</intervention_name>
    <arm_group_label>TAP20-C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SAFE-T-FILL CAPILLARY BLOOD COLLECTION SYSTEM</intervention_name>
    <arm_group_label>SAFE-T-FILL CAPILLARY SYSTEM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy Subject Group

        1. Male and female volunteers 18 years of age or older

        Diabetic Subject Group

          1. Male and female volunteers 18 years of age or older

          2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report

        Exclusion Criteria:

        1.Subjects who are pregnant or nursing mothers by self report 2.Subjects who have eaten or
        consumed sugar-containing drinks in the 2 hours before blood sample collection begins
        3.Subjects with a history of skin disorders or who present with abnormal skin integrity or
        atypical skin health within the areas to be tested 4.Subjects with a missing index or
        middle finger on either hand or a missing forearm 5.Subjects who have known allergies to
        titanium

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seventh Sense BIosystems</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 10, 2013</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
